Related Experiment Videos
Ras effectors
1CRC Centre for Cell and Molecular Biology, Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London SW3 6JB, UK. chrism@icr.ac.uk
Abstract:
The search for proteins which interact with the active GTP-bound form of Ras in order to transmit signals for proliferation, differentiation and oncogenesis has been a long one. Now there are several strong candidates for Ras effectors that include protein kinases, lipid kinases and guanine nucleotide exchange factors. Structural information on how one Ras-binding domain in an effector interacts with Ras.GTP has recently been obtained. Recent data show that transformation by Ras oncoproteins requires the activation of several signal transduction pathways, including those which transmit signals via members of the Rho family of GTPases.
Insights
Identifying Ras effector proteins is crucial for understanding cell signaling in proliferation, differentiation, and oncogenesis. Recent studies reveal key Ras-binding domains and pathways, including Rho GTPases, involved in Ras-driven cancer.
Area of Science:
- Molecular Biology
- Cell Signaling
- Oncogenesis
Background:
- The Ras signaling pathway is central to cell growth, differentiation, and cancer.
- Identifying proteins that interact with the active GTP-bound form of Ras (Ras-GTP) is essential for understanding signal transmission.
- Ras oncoproteins drive transformation by activating multiple signal transduction pathways.
Purpose of the Study:
- To identify and characterize proteins that act as effectors for Ras-GTP.
- To elucidate the structural mechanisms of Ras-effector interactions.
- To understand the role of Ras-mediated signaling pathways in oncogenesis.
Main Methods:
- Biochemical assays to identify Ras-interacting proteins.
- Structural biology techniques to determine Ras-effector complex structures.
- Cellular assays to assess the functional impact of Ras signaling pathways.
Main Results:
- Several strong candidate Ras effector proteins have been identified, including protein kinases, lipid kinases, and guanine nucleotide exchange factors.
- Structural data elucidating the interaction between Ras-GTP and a Ras-binding domain in an effector has been obtained.
- Ras oncoprotein transformation necessitates the activation of multiple signal transduction pathways, notably those involving Rho family GTPases.
Conclusions:
- The identification of Ras effectors provides critical targets for cancer therapy.
- Understanding Ras-effector interactions at a structural level is key to designing targeted interventions.
- Ras-driven oncogenesis involves complex signaling networks, including those mediated by Rho GTPases, highlighting the need for a comprehensive therapeutic approach.